Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults

Background Quality clinical trials form an essential part of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society Clinical Trials Standing Committee developed and published the first edition of the Guidelines for Controlled Trials of Drugs in Migrain...

Full description

Saved in:
Bibliographic Details
Published inCephalalgia Vol. 38; no. 5; pp. 815 - 832
Main Authors Tassorelli, Cristina, Diener, Hans-Christoph, Dodick, David W, Silberstein, Stephen D, Lipton, Richard B, Ashina, Messoud, Becker, Werner J, Ferrari, Michel D, Goadsby, Peter J, Pozo-Rosich, Patricia, Wang, Shuu-Jiun
Format Journal Article
LanguageEnglish
Published London, England SAGE Publications 01.04.2018
Subjects
Chronic migraine
clinical trials
headache
drugs
preventive treatment
Online AccessGet full text

Cover

Abstract Background Quality clinical trials form an essential part of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society Clinical Trials Standing Committee developed and published the first edition of the Guidelines for Controlled Trials of Drugs in Migraine. In 2008, the Committee published the first specific guidelines on chronic migraine. Subsequent advances in drug, device, and biologicals development, as well as novel trial designs, have created a need for a revision of the chronic migraine guidelines. Objective The present update is intended to optimize the design of controlled trials of preventive treatment of chronic migraine in adults, and its recommendations do not apply to trials in children or adolescents.
AbstractList Background Quality clinical trials form an essential part of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society Clinical Trials Standing Committee developed and published the first edition of the Guidelines for Controlled Trials of Drugs in Migraine. In 2008, the Committee published the first specific guidelines on chronic migraine. Subsequent advances in drug, device, and biologicals development, as well as novel trial designs, have created a need for a revision of the chronic migraine guidelines. Objective The present update is intended to optimize the design of controlled trials of preventive treatment of chronic migraine in adults, and its recommendations do not apply to trials in children or adolescents.
Background Quality clinical trials form an essential part of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society Clinical Trials Standing Committee developed and published the first edition of the Guidelines for Controlled Trials of Drugs in Migraine. In 2008, the Committee published the first specific guidelines on chronic migraine. Subsequent advances in drug, device, and biologicals development, as well as novel trial designs, have created a need for a revision of the chronic migraine guidelines. Objective The present update is intended to optimize the design of controlled trials of preventive treatment of chronic migraine in adults, and its recommendations do not apply to trials in children or adolescents.
Background Quality clinical trials form an essential part of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society Clinical Trials Standing Committee developed and published the first edition of the Guidelines for Controlled Trials of Drugs in Migraine. In 2008, the Committee published the first specific guidelines on chronic migraine. Subsequent advances in drug, device, and biologicals development, as well as novel trial designs, have created a need for a revision of the chronic migraine guidelines. Objective The present update is intended to optimize the design of controlled trials of preventive treatment of chronic migraine in adults, and its recommendations do not apply to trials in children or adolescents.Background Quality clinical trials form an essential part of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society Clinical Trials Standing Committee developed and published the first edition of the Guidelines for Controlled Trials of Drugs in Migraine. In 2008, the Committee published the first specific guidelines on chronic migraine. Subsequent advances in drug, device, and biologicals development, as well as novel trial designs, have created a need for a revision of the chronic migraine guidelines. Objective The present update is intended to optimize the design of controlled trials of preventive treatment of chronic migraine in adults, and its recommendations do not apply to trials in children or adolescents.
Author Lipton, Richard B
Goadsby, Peter J
Silberstein, Stephen D
Pozo-Rosich, Patricia
Dodick, David W
Ashina, Messoud
Tassorelli, Cristina
Diener, Hans-Christoph
Becker, Werner J
Ferrari, Michel D
Wang, Shuu-Jiun
Author_xml – sequence: 1
  givenname: Cristina
  orcidid: 0000-0003-1513-2113
  surname: Tassorelli
  fullname: Tassorelli, Cristina
  email: cristina.tassorelli@mondino.it
  organization: Neurological Institute, Taipei Veterans General Hospital and Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan
– sequence: 2
  givenname: Hans-Christoph
  orcidid: 0000-0002-6556-8612
  surname: Diener
  fullname: Diener, Hans-Christoph
  organization: Neurological Institute, Taipei Veterans General Hospital and Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan
– sequence: 3
  givenname: David W
  orcidid: 0000-0002-9486-6790
  surname: Dodick
  fullname: Dodick, David W
  organization: Neurological Institute, Taipei Veterans General Hospital and Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan
– sequence: 4
  givenname: Stephen D
  surname: Silberstein
  fullname: Silberstein, Stephen D
  organization: Neurological Institute, Taipei Veterans General Hospital and Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan
– sequence: 5
  givenname: Richard B
  surname: Lipton
  fullname: Lipton, Richard B
  organization: Neurological Institute, Taipei Veterans General Hospital and Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan
– sequence: 6
  givenname: Messoud
  surname: Ashina
  fullname: Ashina, Messoud
  organization: Neurological Institute, Taipei Veterans General Hospital and Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan
– sequence: 7
  givenname: Werner J
  surname: Becker
  fullname: Becker, Werner J
  organization: Neurological Institute, Taipei Veterans General Hospital and Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan
– sequence: 8
  givenname: Michel D
  surname: Ferrari
  fullname: Ferrari, Michel D
  organization: Neurological Institute, Taipei Veterans General Hospital and Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan
– sequence: 9
  givenname: Peter J
  orcidid: 0000-0003-3260-5904
  surname: Goadsby
  fullname: Goadsby, Peter J
  organization: Neurological Institute, Taipei Veterans General Hospital and Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan
– sequence: 10
  givenname: Patricia
  surname: Pozo-Rosich
  fullname: Pozo-Rosich, Patricia
  organization: Neurological Institute, Taipei Veterans General Hospital and Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan
– sequence: 11
  givenname: Shuu-Jiun
  surname: Wang
  fullname: Wang, Shuu-Jiun
  organization: Neurological Institute, Taipei Veterans General Hospital and Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29504482$$D View this record in MEDLINE/PubMed
BookMark eNp9kTtLBDEUhYMouj56K0lpM5rXzGRKEV0FwUKth2zmRiOZZE0yguCPN-uqhaBVknPPdwPn7KJNHzwgdEjJCaVte0o455QwQWVbSyb5BppR0ciKdZJtotlqXK3mO2g3pWdCSN2QZhvtsK4mQkg2Q-_zyQ7grIeEg8H5CfC1zxC9yjZ45fAVqEHpIt8FbSG_YRMi1sHnGJyDAedolftklxFewWf7CkUElcfyWOn6KQZvNR7tY1TlI2w9VsPkctpHW6bAcPB17qGHy4v786vq5nZ-fX52U2kh6lyxFmpCielMo1q6IFLWICjwrm51pwhQqQYJnA9sUKaruSgXaEBzZXQjF4bvoeP13mUMLxOk3I82aXBOeQhT6lnZLgVteFusR1_WaTHC0C-jHVV8678TKwayNugYUopgfiyU9KtS-t-lFKT5hWibP_PNJRD3H1itwaQeoX8OU6nFpb_9H9i0nfM
CitedBy_id crossref_primary_10_1111_ner_13292
crossref_primary_10_1186_s12883_022_02591_8
crossref_primary_10_1007_s11916_018_0729_x
crossref_primary_10_1093_pm_pnad141
crossref_primary_10_14412_2074_2711_2022_5_109_116
crossref_primary_10_1007_s12325_021_01897_2
crossref_primary_10_3390_pharmaceutics12121180
crossref_primary_10_1016_j_brs_2021_10_383
crossref_primary_10_1111_head_14693
crossref_primary_10_1177_03331024241313377
crossref_primary_10_1212_WNL_0000000000207544
crossref_primary_10_1177_2515816320930681
crossref_primary_10_1186_s10194_022_01503_y
crossref_primary_10_1080_14737175_2024_2365312
crossref_primary_10_1177_03331024211028966
crossref_primary_10_1016_j_heliyon_2023_e16187
crossref_primary_10_1016_S0140_6736_20_32624_6
crossref_primary_10_1590_1806_9282_023d701
crossref_primary_10_1186_s10194_022_01480_2
crossref_primary_10_1186_s10194_020_01189_0
crossref_primary_10_1111_head_13907
crossref_primary_10_1177_0333102420925540
crossref_primary_10_1007_s42451_020_00163_z
crossref_primary_10_1186_s10194_021_01267_x
crossref_primary_10_1016_j_nicl_2023_103531
crossref_primary_10_1093_pm_pnaa436
crossref_primary_10_1093_brain_awac109
crossref_primary_10_1016_j_neurop_2022_01_009
crossref_primary_10_1111_head_14441
crossref_primary_10_1097_WCO_0000000000001267
crossref_primary_10_1177_03331024231166625
crossref_primary_10_1177_03331024211010413
crossref_primary_10_1186_s41687_023_00552_4
crossref_primary_10_1177_03331024251317448
crossref_primary_10_1177_2150132720959936
crossref_primary_10_1212_WNL_0000000000207672
crossref_primary_10_1007_s15016_024_3726_9
crossref_primary_10_1016_j_clinph_2024_02_012
crossref_primary_10_1161_CIRCINTERVENTIONS_120_009841
crossref_primary_10_1097_AJP_0000000000001023
crossref_primary_10_1212_WNL_0000000000010000
crossref_primary_10_1002_brb3_2820
crossref_primary_10_1186_s10194_022_01428_6
crossref_primary_10_3390_medicina59081380
crossref_primary_10_48208_HeadacheMed_2024_35
crossref_primary_10_1186_s10194_020_01130_5
crossref_primary_10_1177_03331024241261077
crossref_primary_10_1007_s15005_022_2311_7
crossref_primary_10_3390_jcm13030690
crossref_primary_10_1111_ene_16131
crossref_primary_10_1016_j_ejpn_2021_02_008
crossref_primary_10_3390_toxins14120850
crossref_primary_10_3390_jcm14030861
crossref_primary_10_1080_17425255_2024_2409253
crossref_primary_10_1136_bmjopen_2020_045969
crossref_primary_10_19161_etd_1263664
crossref_primary_10_1177_0333102419828967
crossref_primary_10_1007_s12325_022_02233_y
crossref_primary_10_1111_head_13929
crossref_primary_10_1186_s10194_019_0961_8
crossref_primary_10_3389_fneur_2023_1190062
crossref_primary_10_3390_children10111764
crossref_primary_10_1177_03331024231197118
crossref_primary_10_1016_S1474_4422_22_00185_5
crossref_primary_10_1177_03331024241273967
crossref_primary_10_1007_s10072_024_07611_8
crossref_primary_10_1111_ene_15458
crossref_primary_10_1177_03331024211047454
crossref_primary_10_3389_fnmol_2022_967103
crossref_primary_10_3390_jcm12175619
crossref_primary_10_1002_14651858_CD015505
crossref_primary_10_1111_ene_16542
crossref_primary_10_3390_cells12010143
crossref_primary_10_1093_brain_awz052
crossref_primary_10_1111_head_13569
crossref_primary_10_1089_neu_2019_6601
crossref_primary_10_1177_03331024241248833
crossref_primary_10_1186_s10194_019_1067_z
crossref_primary_10_1177_0333102421989247
crossref_primary_10_1186_s10194_020_01204_4
crossref_primary_10_1177_03331024221092423
crossref_primary_10_1177_25158163241292307
crossref_primary_10_5124_jkma_2020_63_10_644
crossref_primary_10_1177_03331024231170807
crossref_primary_10_1186_s10194_024_01752_z
crossref_primary_10_1136_bmjopen_2022_068616
crossref_primary_10_1007_s11136_020_02623_1
crossref_primary_10_2217_bem_2019_0024
crossref_primary_10_3390_life14070910
crossref_primary_10_1186_s10194_021_01230_w
crossref_primary_10_1177_25158163211033969
crossref_primary_10_3390_jcm11041117
crossref_primary_10_1007_s40120_023_00575_5
crossref_primary_10_1590_0004_282x20190004
crossref_primary_10_1002_jnr_25161
crossref_primary_10_3389_fphar_2021_671845
crossref_primary_10_1186_s12883_021_02196_7
crossref_primary_10_1007_s15005_023_3426_1
crossref_primary_10_3389_fneur_2022_919623
crossref_primary_10_3390_app11177780
crossref_primary_10_3390_jcm13071964
crossref_primary_10_1007_s42399_024_01759_2
crossref_primary_10_1186_s10194_020_01182_7
crossref_primary_10_3389_fpain_2023_1054764
crossref_primary_10_1177_03331024231152169
crossref_primary_10_12688_healthopenres_13319_3
crossref_primary_10_12688_healthopenres_13319_2
crossref_primary_10_1177_0333102420974004
crossref_primary_10_1111_head_14664
crossref_primary_10_1016_j_pmr_2022_01_007
crossref_primary_10_1177_0333102420956711
crossref_primary_10_1007_s40122_020_00199_9
crossref_primary_10_1136_bmjopen_2022_071443
crossref_primary_10_1177_03331024241298642
crossref_primary_10_1177_03331024241291574
crossref_primary_10_1136_bmjopen_2020_043242
crossref_primary_10_3390_diagnostics14030330
crossref_primary_10_1016_S0140_6736_20_32342_4
crossref_primary_10_12968_bjnn_2020_16_1_16
crossref_primary_10_1177_03331024231159366
crossref_primary_10_1177_03331024241269735
crossref_primary_10_1002_brb3_2526
crossref_primary_10_1002_14651858_CD012295_pub2
crossref_primary_10_1016_j_conctc_2021_100762
crossref_primary_10_3390_toxins13060432
crossref_primary_10_1093_pm_pnab236
crossref_primary_10_1111_papr_12902
crossref_primary_10_1177_03331024221090206
crossref_primary_10_1111_head_14292
crossref_primary_10_1001_jamanetworkopen_2022_15499
crossref_primary_10_1007_s11916_023_01120_7
crossref_primary_10_3310_PLJL1440
crossref_primary_10_1038_s41582_024_01002_5
crossref_primary_10_17340_jkna_2020_2_3
crossref_primary_10_1007_s40271_021_00525_z
crossref_primary_10_2147_JPR_S407738
crossref_primary_10_48208_HeadacheMed_2021_30
crossref_primary_10_1080_17425255_2023_2280221
crossref_primary_10_1038_s41598_021_83508_2
crossref_primary_10_1186_s10194_024_01878_0
crossref_primary_10_1136_bmj_2021_067670
crossref_primary_10_1097_PRS_0000000000010800
crossref_primary_10_1177_20494637211014544
crossref_primary_10_3389_fneur_2022_1032103
crossref_primary_10_1186_s10194_021_01368_7
crossref_primary_10_1177_03331024251318016
crossref_primary_10_1186_s10194_020_01157_8
crossref_primary_10_1007_s40120_023_00538_w
crossref_primary_10_1016_j_jpain_2020_06_006
crossref_primary_10_1097_MD_0000000000018929
crossref_primary_10_1016_j_clinph_2023_03_013
crossref_primary_10_1177_03331024221099035
crossref_primary_10_1177_03331024231206781
crossref_primary_10_3389_fneur_2020_575130
crossref_primary_10_3389_fphar_2022_924994
crossref_primary_10_1186_s10194_023_01611_3
crossref_primary_10_1111_head_13420
crossref_primary_10_1016_j_ncl_2019_06_002
crossref_primary_10_1111_head_13785
crossref_primary_10_1177_0333102419847751
crossref_primary_10_1111_head_14196
crossref_primary_10_1186_s12883_021_02123_w
crossref_primary_10_1212_WNL_0000000000200292
crossref_primary_10_1111_ner_13465
crossref_primary_10_1097_WCO_0000000000000689
crossref_primary_10_1177_0333102420941839
crossref_primary_10_1177_0333102419842188
crossref_primary_10_1097_j_pain_0000000000002341
crossref_primary_10_1111_head_14193
crossref_primary_10_1016_j_medcli_2024_02_006
crossref_primary_10_1136_jnnp_2018_320113
crossref_primary_10_17340_jkna_2020_3_1
crossref_primary_10_1177_17407745241304706
crossref_primary_10_1111_head_14739
crossref_primary_10_1177_0333102420942230
crossref_primary_10_1186_s10194_023_01671_5
crossref_primary_10_1111_head_14743
crossref_primary_10_1177_03331024221120266
crossref_primary_10_3390_jcm12010122
crossref_primary_10_3389_fpain_2022_770397
crossref_primary_10_1111_head_13774
crossref_primary_10_1111_head_14069
crossref_primary_10_3390_nu12061892
crossref_primary_10_1111_head_14067
crossref_primary_10_1007_s15016_022_9490_9
crossref_primary_10_1007_s40122_020_00198_w
crossref_primary_10_17116_rosrino201927041195
crossref_primary_10_1177_25158163221134593
crossref_primary_10_1186_s10194_019_1051_7
crossref_primary_10_1111_head_14808
crossref_primary_10_1186_s10194_018_0951_2
crossref_primary_10_1016_j_medcle_2024_02_011
crossref_primary_10_1177_2515816320964401
crossref_primary_10_1186_s12883_022_02774_3
crossref_primary_10_1111_head_14257
crossref_primary_10_1111_head_14258
crossref_primary_10_1111_jcpt_13620
crossref_primary_10_1111_head_14255
crossref_primary_10_1111_ner_13409
crossref_primary_10_1186_s10194_024_01842_y
crossref_primary_10_1111_head_14498
crossref_primary_10_1186_s42466_020_00057_1
crossref_primary_10_1007_s10072_021_05453_2
crossref_primary_10_1177_0333102419863023
crossref_primary_10_1007_s40122_021_00253_0
crossref_primary_10_1007_s40122_021_00276_7
crossref_primary_10_1186_s10194_022_01418_8
crossref_primary_10_1111_ene_15740
crossref_primary_10_1177_03331024251320608
crossref_primary_10_1177_25158163221075596
crossref_primary_10_1177_03331024231178237
crossref_primary_10_1111_head_13946
crossref_primary_10_1177_03331024231201576
crossref_primary_10_1007_s13311_021_01128_0
crossref_primary_10_1111_ene_15075
crossref_primary_10_1186_s10194_022_01433_9
crossref_primary_10_1111_head_14126
crossref_primary_10_1186_s10194_018_0914_7
crossref_primary_10_3389_fneur_2021_805334
crossref_primary_10_1111_head_14124
crossref_primary_10_1016_j_mehy_2022_110812
crossref_primary_10_1007_s00415_019_09673_7
crossref_primary_10_1186_s10194_021_01366_9
crossref_primary_10_1186_s12883_023_03149_y
crossref_primary_10_1177_03331024221143541
crossref_primary_10_1177_03331024211033829
crossref_primary_10_1038_s41598_023_42110_4
crossref_primary_10_1007_s10072_021_05080_x
crossref_primary_10_3389_fneur_2023_1226591
crossref_primary_10_1111_head_13735
crossref_primary_10_1007_s10072_021_05491_w
crossref_primary_10_1016_j_cden_2022_07_012
crossref_primary_10_1111_head_14153
crossref_primary_10_1186_s10194_023_01587_0
crossref_primary_10_1097_MD_0000000000032600
crossref_primary_10_1177_03331024241234068
crossref_primary_10_1177_03331024241235156
crossref_primary_10_1177_03331024241262751
crossref_primary_10_1371_journal_pone_0265137
crossref_primary_10_1186_s12883_021_02220_w
crossref_primary_10_1212_WNL_0000000000009169
crossref_primary_10_1177_2515816320928463
crossref_primary_10_1002_ejp_1831
crossref_primary_10_1080_14737167_2023_2219898
crossref_primary_10_1177_03331024221076481
crossref_primary_10_1111_ene_16062
crossref_primary_10_1016_j_jbmt_2024_12_011
crossref_primary_10_1016_j_semerg_2020_12_004
crossref_primary_10_1186_s10194_020_01212_4
crossref_primary_10_1111_head_14026
crossref_primary_10_1055_a_1687_9822
crossref_primary_10_1016_j_banm_2020_01_020
crossref_primary_10_30565_medalanya_1148828
crossref_primary_10_3389_fneur_2023_1176816
crossref_primary_10_1111_head_14260
crossref_primary_10_1111_ane_13634
Cites_doi 10.1046/j.1468-29821995.1506452.x
10.1177/0333102410364677
10.1111/j.1468-2982.2008.01786.x
10.1037/t06708-000
10.1046/j.1468-2982.1981.0103127.x
10.1046/j.1468-2982.2000.00117.x
10.1001/jama.2013.281053
10.1093/oxfordjournals.aje.a116014
10.1016/j.pain.2012.12.010
10.1177/0333102416660549
10.1111/j.1468-1331.2011.03497.x
10.1016/j.jns.2013.05.003
10.1037/a0015808
10.1159/000110232
10.1111/j.1468-2982.2007.01326.x
10.1001/archinte.166.10.1092
10.1159/000110120
10.1111/j.1526-4610.2006.00684.x
10.1007/s11136-010-9783-5
10.1038/nrneurol.2016.124
10.1176/appi.books.9780890425596
10.1212/WNL.56.suppl_1.S20
10.1111/j.1600-0773.1990.tb00847.x
10.1177/0333102416652092
10.1186/1477-7525-10-65
10.1016/j.jpain.2014.11.004
10.1111/j.1468-2982.2009.01948.x
10.1111/j.1468-2982.2008.01555.x
10.1177/0333102415616880
10.1016/S1474-4422(16)30293-9
10.1212/WNL.55.5.629
10.1038/nrneurol.2016.93
10.1111/j.1526-4610.2006.00633.x
10.1007/s00415-012-6725-x
10.1111/j.1600-0447.1983.tb09716.x
10.1046/j.1525-1497.2001.016009606.x
10.1111/j.1526-4610.2011.01997.x
10.1007/s11910-010-0175-6
10.1177/0333102416678382
10.1111/j.1468-2982.1998.1807505.x
10.1212/WNL.0000000000002471
10.1212/WNL.0b013e318232ab65
10.1177/0333102414547138
10.1037/t00742-000
10.1007/s10194-012-0447-4
10.1016/j.jclinepi.2005.05.010
10.2165/00019053-199304050-00006
10.1159/000110125
10.1177/0333102414521508
10.1111/j.1468-2982.2008.01752.x
10.1159/000110121
10.1186/s12955-016-0542-3
10.1046/j.1468-2982.1995.015003165.x
10.1016/S1474-4422(07)70272-7
10.1046/j.1468-2982.1999.019008699.x
10.3390/ijerph8010015
10.1111/head.12878
10.1007/978-1-349-08943-7_5
10.1007/978-1-4613-1495-0_15
10.1186/s10194-017-0787-1
10.1111/j.1526-4610.2007.00950.x
10.1111/j.1468-2982.2009.01852.x
10.1177/0333102410364676
ContentType Journal Article
Copyright International Headache Society 2018
Copyright_xml – notice: International Headache Society 2018
CorporateAuthor for the International Headache Society Clinical Trials Standing Committee
International Headache Society Clinical Trials Standing Committee
CorporateAuthor_xml – name: for the International Headache Society Clinical Trials Standing Committee
– name: International Headache Society Clinical Trials Standing Committee
DBID AAYXX
CITATION
NPM
7X8
DOI 10.1177/0333102418758283
DatabaseName CrossRef
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList PubMed

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1468-2982
EndPage 832
ExternalDocumentID 29504482
10_1177_0333102418758283
10.1177_0333102418758283
Genre Journal Article
GroupedDBID ---
-TM
.2F
.2G
.3N
.GJ
.Y3
01A
0R~
1OC
29B
31S
31T
31Y
31~
36B
4.4
53G
54M
5GY
5RE
5VS
6PF
8-1
AABMB
AABOD
AACKU
AADUE
AAGGD
AAHHS
AAJIQ
AAJOX
AAJPV
AANSI
AAPEO
AAQDB
AAQXH
AARDL
AARIX
AASGM
AAWTL
AAXOT
AAYTG
AAZBJ
ABAWC
ABAWP
ABCCA
ABCQN
ABDBF
ABDWY
ABEIX
ABFWQ
ABHKI
ABIVO
ABJIS
ABJNI
ABKRH
ABNCE
ABPGX
ABQKF
ABQXT
ABRHV
ABVFX
ABVVC
ABYTW
ACARO
ACCFJ
ACDSZ
ACDXX
ACFMA
ACFYK
ACGBL
ACGFS
ACLHI
ACNXM
ACOFE
ACROE
ACRPL
ACUHS
ACXQS
ADBBV
ADEBD
ADEIA
ADMPF
ADNBR
ADNMO
ADOGD
ADSTG
ADTBJ
ADUKL
ADYCS
ADZOD
ADZYD
ADZZY
AECVZ
AEEZP
AENEX
AEQDE
AEQLS
AERKM
AEUHG
AEWDL
AEXFG
AEXNY
AFBPY
AFCOW
AFEBI
AFEET
AFKBI
AFKRG
AFRWT
AFUIA
AFVCE
AFWMB
AFZJQ
AGNHF
AGQPQ
AHEFC
AIGRN
AIWBW
AJABX
AJAOE
AJBDE
AJEFB
AJMMQ
AJSCY
AJUZI
AJXGE
ALMA_UNASSIGNED_HOLDINGS
ARTOV
ASPBG
AUTPY
AVWKF
AYAKG
AZFZN
B8M
B8O
B93
BDDNI
BFHJK
BKSCU
BSEHC
BYIEH
CAG
CBRKF
CDWPY
CFDXU
CO8
COF
CORYS
CQQTX
CS3
CUTAK
DC-
DC.
DC0
DC6
DCZOG
DD-
DD0
DE-
DOPDO
DU5
D~Y
EAD
EAP
EAS
EBC
EBD
EBS
EBX
ECV
EJD
EMB
EMK
EMOBN
ENC
EPT
ESX
F5P
FEDTE
FZ0
GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION
H13
HF~
HVGLF
HZI
HZ~
IHE
J8X
K.F
K.J
LH4
LW6
N9A
O9-
OIG
OVD
P.B
P2P
Q1R
Q7K
Q7R
Q7X
Q82
Q~Q
ROL
S01
SASJQ
SAUOL
SCDPB
SCNPE
SFC
SV3
TEORI
TUS
W99
WYUIH
YFH
ZGI
ZONMY
ZPPRI
ZRKOI
ZSSAH
AAYXX
ACHEB
CITATION
31X
AADTT
AAMGE
AATBZ
ACGZU
ACSBE
ACSIQ
ACTQU
ACUIR
AEUIJ
AEWHI
AIOMO
B8Z
DV7
K97
M4V
NPM
7X8
ID FETCH-LOGICAL-c445t-27e5010f9f6a71b0885e41e3957c9a0e18ad8e33d2daf9534d2de6ec3afc68bf3
IEDL.DBID AFRWT
ISSN 0333-1024
1468-2982
IngestDate Fri Jul 11 02:36:03 EDT 2025
Wed Feb 19 02:34:48 EST 2025
Tue Jul 01 05:25:42 EDT 2025
Thu Apr 24 23:09:57 EDT 2025
Tue Jun 17 22:45:34 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Chronic migraine
clinical trials
headache
drugs
preventive treatment
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c445t-27e5010f9f6a71b0885e41e3957c9a0e18ad8e33d2daf9534d2de6ec3afc68bf3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Instructional Material/Guideline-3
content type line 23
ORCID 0000-0002-9486-6790
0000-0003-1513-2113
0000-0002-6556-8612
0000-0003-3260-5904
OpenAccessLink https://journals.sagepub.com/doi/pdf/10.1177/0333102418758283
PMID 29504482
PQID 2010841637
PQPubID 23479
PageCount 18
ParticipantIDs proquest_miscellaneous_2010841637
pubmed_primary_29504482
crossref_primary_10_1177_0333102418758283
crossref_citationtrail_10_1177_0333102418758283
sage_journals_10_1177_0333102418758283
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-04-01
PublicationDateYYYYMMDD 2018-04-01
PublicationDate_xml – month: 04
  year: 2018
  text: 2018-04-01
  day: 01
PublicationDecade 2010
PublicationPlace London, England
PublicationPlace_xml – name: London, England
– name: England
PublicationTitle Cephalalgia
PublicationTitleAlternate Cephalalgia
PublicationYear 2018
Publisher SAGE Publications
Publisher_xml – name: SAGE Publications
References Hepp, Dodick, Varon 2015; 35
Lipton 2000; 55
Aurora, Dodick, Turkel 2010; 30
Lipton, Manack Adams, Buse 2016; 56
Bagley, Rendas-Baum, Maglinte 2012; 52
Ferguson 2009; 40
Evers, Marziniak, Frese 2009; 29
Hougaard, Tfelt-Hansen 2016; 36
1991; 11
Diener, Agosti, Allais 2007; 6
Diener, Dowson, Ferrari 1999; 19
Serrano, Lipton, Scher 2017; 18
Kroenke, Spitzer, Williams 2009; 50
Hepp, Dodick, Varon 2017; 37
Yoon, Manack, Schramm 2013; 154
Stewart, Linet, Celentano 1991; 134
Bendtsen, Bigal, Cerbo 2010; 30
Kroenke, Spitzer, Williams 2001; 16
Bigal, Lipton 2011; 11
Stewart, Lipton, Dowson 2001; 56
Silberstein, Tfelt-Hansen, Dodick 2008; 28
Marrie, Miller, Sormani 2016; 86
Lipton, Kolodner, Bigal 2009; 29
Tassorelli, Jensen, Allena 2017; 37
Mannix, Skalicky, Buse 2016; 14
Vetvik, MacGregor 2017; 16
Coeytaux, Kaufman, Chao 2006; 59
Buse, Silberstein, Manack 2013; 260
Lewis 1987; 6
Silberstein, Blumenfeld, Cady 2013; 331
Olesen, Krabbe, Tfelt-Hansen 1981; 1
Diener, Dodick, Aurora 2010; 30
Lipton, Varon, Grosberg 2011; 77
Chen, Tang, Ng 2012; 13
Silberstein, Cady, Sheftell 2007; 47
Kunkel 1987; 6
Evers, Jensen 2011; 18
Dodick, Silberstein, Saper 2007; 47
Murray 1994; 72
Tfelt-Hansen, Olesen 1985; 4
Dodick, Turkel, DeGryse 2015; 16
Cole, Lin, Rupnow 2009; 29
Lipton, Rosen, Ailani 2016; 36
May, Schulte 2016; 12
Zigmond, Snaith 1983; 67
Tfelt-Hansen, Block, Dahlof 2000; 20
1990; 67
Stafford, Hareendran, Ng-Mak 2012; 10
Xu, Insinga, Golden 2011; 20
Spitzer, Kroenke, Williams 2006; 166
McGough, Faraone 2009; 6
Schoenen 1995; 15
Efird 2011; 8
Reilly, Zbrozek, Dukes 1993; 4
Diener, Bussone, Van Oene 2007; 27
Lipton, Micieli, Russell 1995; 15
Tassorelli, Jensen, Allena 2014; 34
Hockaday 1987; 6
Silberstein, Lipton, Dodick 2007; 47
Diener, Holle, Solbach 2016; 12
bibr4-0333102418758283
bibr18-0333102418758283
bibr34-0333102418758283
bibr68-0333102418758283
Lipton RB (bibr37-0333102418758283) 2000; 55
bibr5-0333102418758283
bibr51-0333102418758283
bibr25-0333102418758283
bibr42-0333102418758283
bibr27-0333102418758283
bibr3-0333102418758283
bibr35-0333102418758283
bibr78-0333102418758283
bibr60-0333102418758283
bibr17-0333102418758283
bibr43-0333102418758283
Kroenke K (bibr52-0333102418758283) 2009; 50
bibr26-0333102418758283
bibr15-0333102418758283
bibr75-0333102418758283
bibr36-0333102418758283
bibr62-0333102418758283
bibr31-0333102418758283
bibr23-0333102418758283
bibr44-0333102418758283
bibr10-0333102418758283
bibr70-0333102418758283
bibr57-0333102418758283
bibr46-0333102418758283
bibr59-0333102418758283
bibr20-0333102418758283
bibr49-0333102418758283
bibr33-0333102418758283
bibr67-0333102418758283
bibr2-0333102418758283
bibr28-0333102418758283
bibr41-0333102418758283
bibr54-0333102418758283
bibr21-0333102418758283
bibr39-0333102418758283
bibr64-0333102418758283
bibr72-0333102418758283
bibr47-0333102418758283
bibr12-0333102418758283
bibr55-0333102418758283
Meinert CL (bibr7-0333102418758283) 2012
bibr14-0333102418758283
bibr22-0333102418758283
bibr38-0333102418758283
bibr65-0333102418758283
bibr73-0333102418758283
bibr48-0333102418758283
bibr30-0333102418758283
bibr13-0333102418758283
McGough JJ (bibr77-0333102418758283) 2009; 6
bibr56-0333102418758283
Spilker B (bibr8-0333102418758283) 1991
bibr40-0333102418758283
bibr58-0333102418758283
Guidelines for controlled trials of drugs in migraine (bibr1-0333102418758283) 1991; 11
bibr45-0333102418758283
bibr32-0333102418758283
bibr61-0333102418758283
bibr29-0333102418758283
bibr74-0333102418758283
bibr16-0333102418758283
bibr66-0333102418758283
bibr53-0333102418758283
bibr71-0333102418758283
Murray CJ (bibr69-0333102418758283) 1994; 72
Shamley D (bibr9-0333102418758283) 2017
bibr19-0333102418758283
bibr63-0333102418758283
bibr76-0333102418758283
bibr24-0333102418758283
bibr50-0333102418758283
bibr11-0333102418758283
bibr6-0333102418758283
References_xml – volume: 12
  start-page: 575
  year: 2016
  end-page: 583
  article-title: Medication-overuse headache: Risk factors, pathophysiology and management
  publication-title: Nat Rev Neurol
– volume: 86
  start-page: 1437
  year: 2016
  end-page: 1445
  article-title: The challenge of comorbidity in clinical trials for multiple sclerosis
  publication-title: Neurology
– volume: 55
  start-page: S3
  year: 2000
  end-page: 7
  article-title: Methodologic issues in acute migraine clinical trials
  publication-title: Neurology
– volume: 67
  start-page: 361
  year: 1990
  end-page: 372
  article-title: EEC note for guidance: Good clinical practice for trials on medicinal products in the European Community
  publication-title: Pharmacol Toxicol
– volume: 20
  start-page: 765
  year: 2000
  end-page: 786
  article-title: Guidelines for controlled trials of drugs in migraine: Second edition
  publication-title: Cephalalgia
– volume: 29
  start-page: 436
  year: 2009
  end-page: 444
  article-title: Placebo efficacy in childhood and adolescence migraine: An analysis of double-blind and placebo-controlled studies
  publication-title: Cephalalgia
– volume: 260
  start-page: 1960
  year: 2013
  end-page: 1969
  article-title: Psychiatric comorbidities of episodic and chronic migraine
  publication-title: J Neurol
– volume: 6
  start-page: 1054
  year: 2007
  end-page: 1062
  article-title: Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): A randomised, double-blind, placebo-controlled trial
  publication-title: Lancet Neurol
– volume: 18
  start-page: 1115
  year: 2011
  end-page: 1121
  article-title: Treatment of medication overuse headache – guideline of the EFNS headache panel
  publication-title: Eur J Neurol
– volume: 11
  start-page: 1
  year: 1991
  end-page: 16
  article-title: First edition. International Headache Society Committee on Clinical Trials in Migraine
  publication-title: Cephalalgia
– volume: 15
  start-page: 165
  year: 1995
  end-page: 179
  article-title: Guidelines for trials of drug treatments in tension-type headache. First edition: International Headache Society Committee on Clinical Trials
  publication-title: Cephalalgia
– volume: 29
  start-page: 1180
  year: 2009
  end-page: 1187
  article-title: Minimal important differences in the Migraine-Specific Quality of Life Questionnaire (MSQ) version
  publication-title: Cephalalgia
– volume: 40
  start-page: 532
  year: 2009
  end-page: 538
  article-title: An effect size primer: A guide for clinicians and researchers
  publication-title: Prof Psychol Res Pract
– volume: 36
  start-page: 960
  year: 2016
  end-page: 969
  article-title: General lack of use of placebo in prophylactic, randomised, controlled trials in adult migraine. A systematic review
  publication-title: Cephalalgia
– volume: 14
  start-page: 143
  year: 2016
  end-page: 143
  article-title: Measuring the impact of migraine for evaluating outcomes of preventive treatments for migraine headaches
  publication-title: Health Qual Life Outcomes
– volume: 52
  start-page: 409
  year: 2012
  end-page: 421
  article-title: Validating Migraine-Specific Quality of Life Questionnaire v2.1 in episodic and chronic migraine
  publication-title: Headache
– volume: 6
  start-page: 198
  year: 1987
  end-page: 208
  article-title: Migraine trials: Crossover or parallel group?
  publication-title: Neuroepidemiology
– volume: 30
  start-page: 1
  year: 2010
  end-page: 16
  article-title: Guidelines for controlled trials of drugs in tension-type headache: Second edition
  publication-title: Cephalalgia
– volume: 27
  start-page: 814
  year: 2007
  end-page: 823
  article-title: Topiramate reduces headache days in chronic migraine: A randomized, double-blind, placebo-controlled study
  publication-title: Cephalalgia
– volume: 10
  start-page: 65
  year: 2012
  end-page: 65
  article-title: EQ-5D-derived utility values for different levels of migraine severity from a UK sample of migraineurs
  publication-title: Health Qual Life Outcomes
– volume: 56
  start-page: S20
  year: 2001
  end-page: S28
  article-title: Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability
  publication-title: Neurology
– volume: 47
  start-page: 170
  year: 2007
  end-page: 180
  article-title: Efficacy and safety of topiramate for the treatment of chronic migraine: A randomized, double-blind, placebo-controlled trial
  publication-title: Headache
– volume: 1
  start-page: 127
  year: 1981
  end-page: 141
  article-title: Methodological aspects of prophylactic drug trials in migraine
  publication-title: Cephalalgia
– volume: 47
  start-page: 1398
  year: 2007
  end-page: 1408
  article-title: The impact of topiramate on health-related quality of life indicators in chronic migraine
  publication-title: Headache
– volume: 4
  start-page: 204
  year: 1985
  end-page: 226
  article-title: Methodological aspects of drug trials in migraine
  publication-title: Neuroepidemiology
– volume: 12
  start-page: 455
  year: 2016
  end-page: 464
  article-title: Chronic migraine: Risk factors, mechanisms and treatment
  publication-title: Nat Rev Neurol
– volume: 331
  start-page: 48
  year: 2013
  end-page: 56
  article-title: OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline
  publication-title: J Neurol Sci
– volume: 47
  start-page: 673
  year: 2007
  end-page: 682
  article-title: Efficacy of eletriptan in migraine-related functional impairment: Functional and work productivity outcomes
  publication-title: Headache
– volume: 50
  start-page: 613
  year: 2009
  end-page: 621
  article-title: An ultra-brief screening scale for anxiety and depression: The PHQ-4
  publication-title: Psychosomatics
– volume: 37
  start-page: 1115
  year: 2017
  end-page: 1125
  article-title: The added value of an electronic monitoring and alerting system in the management of medication-overuse headache: A controlled multicentre study
  publication-title: Cephalalgia
– volume: 11
  start-page: 139
  year: 2011
  end-page: 148
  article-title: Migraine chronification
  publication-title: Curr Neurol Neurosci Rep
– volume: 6
  start-page: 234
  year: 1987
  end-page: 238
  article-title: Problems in childhood migraine
  publication-title: Neuroepidemiology
– volume: 20
  start-page: 601
  year: 2011
  end-page: 608
  article-title: EuroQol (EQ-5D) health utility scores for patients with migraine
  publication-title: Qual Life Res
– volume: 67
  start-page: 361
  year: 1983
  end-page: 370
  article-title: The hospital anxiety and depression scale
  publication-title: Acta Psychiatr Scand
– volume: 72
  start-page: 429
  year: 1994
  end-page: 445
  article-title: Quantifying the burden of disease: The technical basis for disability-adjusted life years
  publication-title: Bull World Health Organ
– volume: 37
  start-page: 470
  year: 2017
  end-page: 485
  article-title: Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis
  publication-title: Cephalalgia
– volume: 30
  start-page: 793
  year: 2010
  end-page: 803
  article-title: OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial
  publication-title: Cephalalgia
– volume: 16
  start-page: 164
  year: 2015
  end-page: 175
  article-title: Assessing clinically meaningful treatment effects in controlled trials: Chronic migraine as an example
  publication-title: J Pain
– volume: 30
  start-page: 804
  year: 2010
  end-page: 814
  article-title: OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial
  publication-title: Cephalalgia
– volume: 6
  start-page: 209
  year: 1987
  end-page: 213
  article-title: Clinical trials in migraine: Parallel versus crossover studies
  publication-title: Neuroepidemiology
– volume: 77
  start-page: 1465
  year: 2011
  end-page: 1472
  article-title: OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine
  publication-title: Neurology
– volume: 19
  start-page: 699
  year: 1999
  end-page: 700
  article-title: Unbalanced randomization influences placebo response: Scientific versus ethical issues around the use of placebo in migraine trials
  publication-title: Cephalalgia
– volume: 56
  start-page: 1280
  year: 2016
  end-page: 1289
  article-title: A comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) study and American Migraine Prevalence and Prevention (AMPP) study: Demographics and headache-related disability
  publication-title: Headache
– volume: 4
  start-page: 353
  year: 1993
  end-page: 365
  article-title: The validity and reproducibility of a work productivity and activity impairment instrument
  publication-title: Pharmacoeconomics
– volume: 13
  start-page: 311
  year: 2012
  end-page: 319
  article-title: Comorbidity profiles of chronic migraine sufferers in a national database in Taiwan
  publication-title: J Headache Pain
– volume: 16
  start-page: 76
  year: 2017
  end-page: 87
  article-title: Sex differences in the epidemiology, clinical features, and pathophysiology of migraine
  publication-title: Lancet Neurol
– volume: 18
  start-page: 101
  year: 2017
  end-page: 101
  article-title: Fluctuations in episodic and chronic migraine status over the course of 1 year: Implications for diagnosis, treatment and clinical trial design
  publication-title: J Headache Pain
– volume: 34
  start-page: 645
  year: 2014
  end-page: 655
  article-title: A consensus protocol for the management of medication-overuse headache: Evaluation in a multicentric, multinational study
  publication-title: Cephalalgia
– volume: 134
  start-page: 1111
  year: 1991
  end-page: 1120
  article-title: Age- and sex-specific incidence rates of migraine with and without visual aura
  publication-title: Am J Epidemiol
– volume: 8
  start-page: 15
  year: 2011
  end-page: 20
  article-title: Blocked randomization with randomly selected block sizes
  publication-title: Int J Environ Res Public Health
– volume: 35
  start-page: 478
  year: 2015
  end-page: 488
  article-title: Adherence to oral migraine-preventive medications among patients with chronic migraine
  publication-title: Cephalalgia
– volume: 59
  start-page: 374
  year: 2006
  end-page: 380
  article-title: Four methods of estimating the minimal important difference score were compared to establish a clinically significant change in Headache Impact Test
  publication-title: J Clin Epidemiol
– volume: 16
  start-page: 606
  year: 2001
  end-page: 613
  article-title: The PHQ-9: Validity of a brief depression severity measure
  publication-title: J Gen Intern Med
– volume: 15
  start-page: 452
  year: 1995
  end-page: 462
  article-title: Guidelines for controlled trials of drugs in cluster headache
  publication-title: Cephalalgia
– volume: 36
  start-page: 899
  year: 2016
  end-page: 908
  article-title: OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine over one year of treatment: Pooled results from the PREEMPT randomized clinical trial program
  publication-title: Cephalalgia
– volume: 29
  start-page: 751
  year: 2009
  end-page: 759
  article-title: Validity and reliability of the Migraine-Treatment Optimization Questionnaire
  publication-title: Cephalalgia
– volume: 154
  start-page: 484
  year: 2013
  end-page: 492
  article-title: Chronic migraine and chronic tension-type headache are associated with concomitant low back pain: Results of the German Headache Consortium study
  publication-title: Pain
– volume: 28
  start-page: 484
  year: 2008
  end-page: 495
  article-title: Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults
  publication-title: Cephalalgia
– volume: 166
  start-page: 1092
  year: 2006
  end-page: 1097
  article-title: A brief measure for assessing generalized anxiety disorder: The GAD-7
  publication-title: Arch Intern Med
– volume: 6
  start-page: 21
  year: 2009
  end-page: 29
  article-title: Estimating the size of treatment effects: Moving beyond values
  publication-title: (Edgmont)
– ident: bibr2-0333102418758283
  doi: 10.1046/j.1468-29821995.1506452.x
– ident: bibr73-0333102418758283
– ident: bibr17-0333102418758283
  doi: 10.1177/0333102410364677
– ident: bibr64-0333102418758283
  doi: 10.1111/j.1468-2982.2008.01786.x
– ident: bibr68-0333102418758283
  doi: 10.1037/t06708-000
– ident: bibr44-0333102418758283
  doi: 10.1046/j.1468-2982.1981.0103127.x
– ident: bibr4-0333102418758283
  doi: 10.1046/j.1468-2982.2000.00117.x
– ident: bibr14-0333102418758283
  doi: 10.1001/jama.2013.281053
– ident: bibr23-0333102418758283
  doi: 10.1093/oxfordjournals.aje.a116014
– ident: bibr32-0333102418758283
  doi: 10.1016/j.pain.2012.12.010
– volume: 11
  start-page: 1
  year: 1991
  ident: bibr1-0333102418758283
  publication-title: Cephalalgia
– ident: bibr24-0333102418758283
  doi: 10.1177/0333102416660549
– ident: bibr21-0333102418758283
  doi: 10.1111/j.1468-1331.2011.03497.x
– ident: bibr40-0333102418758283
  doi: 10.1016/j.jns.2013.05.003
– ident: bibr13-0333102418758283
– volume-title: A comprehensive and practical guide to clinical trials
  year: 2017
  ident: bibr9-0333102418758283
– ident: bibr76-0333102418758283
  doi: 10.1037/a0015808
– ident: bibr10-0333102418758283
  doi: 10.1159/000110232
– ident: bibr38-0333102418758283
  doi: 10.1111/j.1468-2982.2007.01326.x
– ident: bibr50-0333102418758283
– ident: bibr56-0333102418758283
  doi: 10.1001/archinte.166.10.1092
– volume-title: Guide to Clinical Trials
  year: 1991
  ident: bibr8-0333102418758283
– ident: bibr42-0333102418758283
  doi: 10.1159/000110120
– ident: bibr39-0333102418758283
  doi: 10.1111/j.1526-4610.2006.00684.x
– ident: bibr67-0333102418758283
  doi: 10.1007/s11136-010-9783-5
– ident: bibr19-0333102418758283
  doi: 10.1038/nrneurol.2016.124
– ident: bibr35-0333102418758283
  doi: 10.1176/appi.books.9780890425596
– volume: 50
  start-page: 613
  year: 2009
  ident: bibr52-0333102418758283
  publication-title: Psychosomatics
– ident: bibr65-0333102418758283
  doi: 10.1212/WNL.56.suppl_1.S20
– ident: bibr70-0333102418758283
  doi: 10.1111/j.1600-0773.1990.tb00847.x
– ident: bibr71-0333102418758283
  doi: 10.1177/0333102416652092
– ident: bibr66-0333102418758283
  doi: 10.1186/1477-7525-10-65
– volume: 72
  start-page: 429
  year: 1994
  ident: bibr69-0333102418758283
  publication-title: Bull World Health Organ
– ident: bibr12-0333102418758283
  doi: 10.1016/j.jpain.2014.11.004
– ident: bibr5-0333102418758283
  doi: 10.1111/j.1468-2982.2009.01948.x
– ident: bibr74-0333102418758283
– ident: bibr6-0333102418758283
  doi: 10.1111/j.1468-2982.2008.01555.x
– ident: bibr11-0333102418758283
  doi: 10.1177/0333102415616880
– ident: bibr29-0333102418758283
  doi: 10.1016/S1474-4422(16)30293-9
– volume: 55
  start-page: S3
  year: 2000
  ident: bibr37-0333102418758283
  publication-title: Neurology
  doi: 10.1212/WNL.55.5.629
– ident: bibr18-0333102418758283
  doi: 10.1038/nrneurol.2016.93
– ident: bibr78-0333102418758283
– ident: bibr58-0333102418758283
  doi: 10.1111/j.1526-4610.2006.00633.x
– ident: bibr33-0333102418758283
  doi: 10.1007/s00415-012-6725-x
– ident: bibr54-0333102418758283
  doi: 10.1111/j.1600-0447.1983.tb09716.x
– ident: bibr51-0333102418758283
  doi: 10.1046/j.1525-1497.2001.016009606.x
– ident: bibr63-0333102418758283
  doi: 10.1111/j.1526-4610.2011.01997.x
– ident: bibr15-0333102418758283
– ident: bibr22-0333102418758283
  doi: 10.1007/s11910-010-0175-6
– ident: bibr27-0333102418758283
  doi: 10.1177/0333102416678382
– ident: bibr36-0333102418758283
  doi: 10.1111/j.1468-2982.1998.1807505.x
– ident: bibr31-0333102418758283
  doi: 10.1212/WNL.0000000000002471
– ident: bibr61-0333102418758283
  doi: 10.1212/WNL.0b013e318232ab65
– ident: bibr28-0333102418758283
  doi: 10.1177/0333102414547138
– ident: bibr53-0333102418758283
  doi: 10.1037/t00742-000
– ident: bibr34-0333102418758283
  doi: 10.1007/s10194-012-0447-4
– ident: bibr60-0333102418758283
  doi: 10.1016/j.jclinepi.2005.05.010
– ident: bibr72-0333102418758283
  doi: 10.2165/00019053-199304050-00006
– ident: bibr75-0333102418758283
– ident: bibr25-0333102418758283
  doi: 10.1159/000110125
– ident: bibr20-0333102418758283
  doi: 10.1177/0333102414521508
– volume-title: Clinical trials: Design, conduct and analysis
  year: 2012
  ident: bibr7-0333102418758283
– ident: bibr26-0333102418758283
  doi: 10.1111/j.1468-2982.2008.01752.x
– volume: 6
  start-page: 21
  year: 2009
  ident: bibr77-0333102418758283
  publication-title: Psychiatry (Edgmont)
– ident: bibr55-0333102418758283
– ident: bibr45-0333102418758283
  doi: 10.1159/000110121
– ident: bibr59-0333102418758283
  doi: 10.1186/s12955-016-0542-3
– ident: bibr3-0333102418758283
  doi: 10.1046/j.1468-2982.1995.015003165.x
– ident: bibr49-0333102418758283
  doi: 10.1016/S1474-4422(07)70272-7
– ident: bibr41-0333102418758283
  doi: 10.1046/j.1468-2982.1999.019008699.x
– ident: bibr43-0333102418758283
  doi: 10.3390/ijerph8010015
– ident: bibr30-0333102418758283
  doi: 10.1111/head.12878
– ident: bibr46-0333102418758283
  doi: 10.1007/978-1-349-08943-7_5
– ident: bibr47-0333102418758283
  doi: 10.1007/978-1-4613-1495-0_15
– ident: bibr48-0333102418758283
  doi: 10.1186/s10194-017-0787-1
– ident: bibr57-0333102418758283
  doi: 10.1111/j.1526-4610.2007.00950.x
– ident: bibr62-0333102418758283
  doi: 10.1111/j.1468-2982.2009.01852.x
– ident: bibr16-0333102418758283
  doi: 10.1177/0333102410364676
SSID ssj0005606
Score 2.6214678
Snippet Background Quality clinical trials form an essential part of the evidence base for the treatment of headache disorders. In 1991, the International Headache...
Background Quality clinical trials form an essential part of the evidence base for the treatment of headache disorders. In 1991, the International Headache...
SourceID proquest
pubmed
crossref
sage
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 815
Title Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults
URI https://journals.sagepub.com/doi/full/10.1177/0333102418758283
https://www.ncbi.nlm.nih.gov/pubmed/29504482
https://www.proquest.com/docview/2010841637
Volume 38
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9swED_SFEpfxj76ka0tGoxCH7w4lvyhp9Fsy8Kgeygt65uR5VMpNE5Z4kGhf_zubDklLRt7M7JkGd1JutPvpzuAD5lyJtSmDIx2mhyUwgbaIDMcZWG0oi054bvDZz-S6aX6fhVf9aDq7sL4EVx8ZFoV_VGzWPPs5tPooQcZh6GUZJbQ5kPWNrkM8lO9nOXtaXeXVINLGJ6uZ4xsW-ZD3gfd7bYN2IzSJI76sHk6Of958UgKScIW3ZTM2IrUI7D5rM_1jeyZdbrGDGs2q8lLeOGtTHHaqsUr6GH1GrbOPI7-Bh6-1RzeiinvYu4EGYFi7WhQTEn0HOpZeFanINtWeFr7LZaiSfbRtL3zMaB-o1iR1rnctlF3xezmmrNQoLipRBPsY7EDl5OvF5-ngc_DEFil4mUQpRiT2-a0S0w6KmhdilGNkBE-q02Io8yUGUpZRqVxOpaKHjBBK42zSVY4uQv9al7hPoiC3linyelRoXJoNA2kK6V1oSzQpGYAw25Qc-uDlHOujNt81MUlfyKGAZysWty1ATr-Ufd9J6ecZhFDI6bCeb3ImRPAAKxMB7DXCnD1tUjHITmx0QCOWaJ5p6J_7ebt_1Z8B9vUcdYSgQ6gv_xV4yHZOMviiBRz_GU8OfIK-gfvjPcf
linkProvider SAGE Publications
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3fb9MwED51rbTtBQEbrOOXkcYkHjLS2EnjBx4qoHRs7QNqRd8yxzlPlbZ0WlsQEv8Q_yXnxOnUVSBe-hYldmL5fL673OfvAI5iYZQvVeYpaSQFKKn2pEKLcOSpkoJMcmTPDvcHUW8kvozDcQ1-V2dh3AzOTiysikZUbNZL7bZMSZyTR0J2hxxtihaqutVn-PMHRWuz96cfSbRvgqD7afih57mCAp4WIpx7QRtDij-MNJFqt1JSsBBFC22qSkvlYytWWYycZ0GmjAy5oAuMUHNldBSnhtN7t6AhQtr469DodL9-G97hSSK_TIxyC_YKxF1OdG3MqzZwzbFdAZUVdq77EB44B5V1yhX1CGqYP4btvkvB78GvzwvLjGXR8mxqGPmPbOWvIuvRqrEs0cwBQhm5xcwh4q8wY0WdkKLvjaOP-o5siXe393VJ2MuuJ5e2gAWySc4KnpDZPow2MuNPoJ5PczwAltITbSTFS8IXBpWkiTQZ18bnKaq2asK7alIT7fjNbZmNq6RVUZrfE0MT3i573JTcHv9o-7qSU0IKaLMqKsfpYpZYOIHN3fJ2E56WAly-LZChT_Fv0IRjK9GkWt1__czh_zZ8BTu9Yf88OT8dnD2DXRpEXOKJnkN9frvAF-QqzdOXbpEyuNi0XvwBb1MeKg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NTqp4QbDxUWDMk8YkHkLT2Enjhz1UjK5b6YSmVewtOM4ZTSppRVvQpP1L_I-cE6dVNw3tpW9RYjvWfeTucj_fAezHwihfqsxT0kgKUFLtSYUW4chTJQWZ5MieHR6cRb2hOL0MLzfgb3UWxlFw-tHCqmhHxcfaavckM02XY2z6nJNXQraHnG2KGKre1X28_kMR2_Tw5IjY-z4Iup8vPvU811TA00KEMy9oY0gxiJEmUu1WSkoWomihTVdpqXxsxSqLkfMsyJSRIRd0gRFqroyO4tRwWvcRbApBMWUNNjvd828XS0xJ5JfJUW4BX4FY5kXv7HnVDt5xbleAZYWt6z6FJ85JZZ1Sqp7BBuZbUB-4NPw23BzPbXUsi5hnY8PIh2QrfxZZjyTHVopmDhTKyDVmDhU_wowVvUKKuRNXQuo3sgXm3d7XZdFe9vPqh21igewqZ0WtkOlzGK6F4i-glo9zfAUspSfaSIqZhC8MKkmENBnXxucpqrZqQLMiaqJdjXPbamOUtKqy5rfY0IAPixmTsr7Hf8buVXxKSAltZkXlOJ5PEwspsPlb3m7Ay5KBi9UCGfoUAwcNOLAcTSoJv_c1rx86cBfqX4-6yZeTs_4beEx7iEtI0VuozX7NcYe8pVn6zskog-_rVot_8DEfQw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Guidelines+of+the+International+Headache+Society+for+controlled+trials+of+preventive+treatment+of+chronic+migraine+in+adults&rft.jtitle=Cephalalgia&rft.au=Tassorelli%2C+Cristina&rft.au=Diener%2C+Hans-Christoph&rft.au=Dodick%2C+David+W&rft.au=Silberstein%2C+Stephen+D&rft.date=2018-04-01&rft.eissn=1468-2982&rft.volume=38&rft.issue=5&rft.spage=815&rft_id=info:doi/10.1177%2F0333102418758283&rft_id=info%3Apmid%2F29504482&rft.externalDocID=29504482
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0333-1024&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0333-1024&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0333-1024&client=summon